Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thiolester Hydrolases | 16 | 2024 | 91 | 6.630 |
Why?
|
Phospholipid Transfer Proteins | 23 | 2024 | 90 | 6.190 |
Why?
|
Liver | 52 | 2023 | 7577 | 3.740 |
Why?
|
Fatty Liver | 14 | 2024 | 809 | 3.320 |
Why?
|
Thermogenesis | 12 | 2024 | 494 | 2.210 |
Why?
|
Fatty Acids | 19 | 2023 | 1812 | 2.170 |
Why?
|
Lipid Metabolism | 21 | 2023 | 1904 | 2.140 |
Why?
|
Triglycerides | 15 | 2023 | 2464 | 1.870 |
Why?
|
Lipogenesis | 10 | 2024 | 217 | 1.860 |
Why?
|
Palmitoyl-CoA Hydrolase | 5 | 2021 | 17 | 1.780 |
Why?
|
Cholesterol | 29 | 2016 | 2914 | 1.730 |
Why?
|
Adipose Tissue, Brown | 13 | 2024 | 776 | 1.720 |
Why?
|
Insulin Resistance | 15 | 2024 | 3986 | 1.700 |
Why?
|
Bile Acids and Salts | 18 | 2019 | 398 | 1.370 |
Why?
|
Energy Metabolism | 15 | 2024 | 2907 | 1.250 |
Why?
|
Glucose | 14 | 2023 | 4352 | 1.240 |
Why?
|
Phosphatidylcholines | 9 | 2023 | 406 | 1.010 |
Why?
|
Lipoproteins | 8 | 2019 | 880 | 0.960 |
Why?
|
Mice, Knockout | 35 | 2024 | 14488 | 0.920 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2024 | 325 | 0.820 |
Why?
|
Homeostasis | 9 | 2020 | 3348 | 0.770 |
Why?
|
Lipoproteins, VLDL | 4 | 2019 | 201 | 0.760 |
Why?
|
Mice | 71 | 2024 | 82029 | 0.760 |
Why?
|
Obesity | 20 | 2024 | 13090 | 0.750 |
Why?
|
Glycolysis | 2 | 2024 | 837 | 0.720 |
Why?
|
Chenodeoxycholic Acid | 1 | 2019 | 34 | 0.670 |
Why?
|
Up-Regulation | 5 | 2024 | 4146 | 0.660 |
Why?
|
Animals | 91 | 2024 | 169246 | 0.660 |
Why?
|
Glycerol-3-Phosphate O-Acyltransferase | 1 | 2018 | 9 | 0.640 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 500 | 0.620 |
Why?
|
Androgen-Binding Protein | 3 | 2002 | 10 | 0.610 |
Why?
|
Muscle, Skeletal | 2 | 2024 | 4978 | 0.590 |
Why?
|
Mice, Inbred C57BL | 28 | 2024 | 22379 | 0.560 |
Why?
|
Mitochondrial Proteins | 4 | 2019 | 979 | 0.530 |
Why?
|
Hepatocytes | 11 | 2022 | 1247 | 0.530 |
Why?
|
Diet | 9 | 2023 | 8089 | 0.520 |
Why?
|
Glucose Intolerance | 3 | 2017 | 579 | 0.500 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2023 | 2333 | 0.480 |
Why?
|
Bile | 4 | 2005 | 299 | 0.480 |
Why?
|
Leptin | 5 | 2016 | 1599 | 0.470 |
Why?
|
Mitochondria | 7 | 2021 | 3681 | 0.470 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2015 | 104 | 0.460 |
Why?
|
Dyslipidemias | 4 | 2016 | 873 | 0.450 |
Why?
|
Anticholesteremic Agents | 2 | 2014 | 972 | 0.450 |
Why?
|
PPAR alpha | 3 | 2010 | 177 | 0.440 |
Why?
|
Calcium Signaling | 1 | 2017 | 737 | 0.420 |
Why?
|
Fibroblast Growth Factors | 4 | 2021 | 873 | 0.420 |
Why?
|
Adaptation, Biological | 1 | 2013 | 147 | 0.410 |
Why?
|
Apolipoproteins B | 1 | 2014 | 386 | 0.410 |
Why?
|
Mouth Diseases | 1 | 2015 | 239 | 0.410 |
Why?
|
Hypercholesterolemia | 5 | 2014 | 1145 | 0.410 |
Why?
|
Fructose | 4 | 2019 | 284 | 0.400 |
Why?
|
Lipoproteins, HDL | 3 | 2007 | 682 | 0.390 |
Why?
|
ATP-Binding Cassette Transporters | 9 | 2014 | 567 | 0.390 |
Why?
|
Insulin | 7 | 2023 | 6607 | 0.390 |
Why?
|
Liver Neoplasms | 4 | 2023 | 4362 | 0.380 |
Why?
|
Mice, Obese | 4 | 2017 | 417 | 0.380 |
Why?
|
Pruritus | 1 | 2015 | 379 | 0.380 |
Why?
|
Oligonucleotides | 1 | 2014 | 563 | 0.370 |
Why?
|
Acyl Coenzyme A | 2 | 2020 | 56 | 0.370 |
Why?
|
Oxidation-Reduction | 5 | 2021 | 2227 | 0.360 |
Why?
|
Carrier Proteins | 8 | 2018 | 4937 | 0.360 |
Why?
|
Calorimetry, Indirect | 4 | 2018 | 176 | 0.330 |
Why?
|
Fruit | 1 | 2015 | 1165 | 0.330 |
Why?
|
Vegetables | 1 | 2015 | 1199 | 0.330 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 5 | 2008 | 28 | 0.300 |
Why?
|
Gene Deletion | 3 | 2013 | 2675 | 0.300 |
Why?
|
Adipose Tissue, White | 6 | 2019 | 371 | 0.300 |
Why?
|
Allylamine | 1 | 2007 | 10 | 0.290 |
Why?
|
Gallstones | 3 | 2008 | 285 | 0.290 |
Why?
|
Mice, Inbred Strains | 5 | 2016 | 1765 | 0.290 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.290 |
Why?
|
Phospholipids | 4 | 2007 | 787 | 0.290 |
Why?
|
Calcium | 2 | 2017 | 5792 | 0.280 |
Why?
|
Mice, Inbred NZB | 1 | 2006 | 57 | 0.280 |
Why?
|
Food Hypersensitivity | 1 | 2015 | 734 | 0.280 |
Why?
|
Paired Box Transcription Factors | 1 | 2007 | 206 | 0.270 |
Why?
|
Gluconeogenesis | 2 | 2020 | 185 | 0.260 |
Why?
|
Thyroid Hormones | 3 | 2021 | 407 | 0.250 |
Why?
|
Glucose Tolerance Test | 4 | 2016 | 1183 | 0.250 |
Why?
|
Dietary Fats | 6 | 2014 | 2003 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 3251 | 0.230 |
Why?
|
Stress, Physiological | 2 | 2024 | 1408 | 0.230 |
Why?
|
Arrestins | 2 | 2017 | 73 | 0.230 |
Why?
|
Apolipoprotein A-I | 2 | 2005 | 305 | 0.230 |
Why?
|
Macrophages, Peritoneal | 1 | 2005 | 244 | 0.230 |
Why?
|
Body Weight | 4 | 2021 | 4627 | 0.230 |
Why?
|
Receptors, Adrenergic, beta | 2 | 2017 | 243 | 0.220 |
Why?
|
Liver Failure | 1 | 2006 | 252 | 0.220 |
Why?
|
Rosacea | 1 | 2024 | 60 | 0.220 |
Why?
|
Lipids | 8 | 2017 | 3343 | 0.210 |
Why?
|
PPAR delta | 1 | 2023 | 40 | 0.210 |
Why?
|
Male | 42 | 2024 | 364719 | 0.210 |
Why?
|
Biological Transport | 5 | 2017 | 2085 | 0.210 |
Why?
|
Enterohepatic Circulation | 1 | 2002 | 12 | 0.210 |
Why?
|
Cholesterol, HDL | 4 | 2015 | 1820 | 0.200 |
Why?
|
Apolipoproteins E | 2 | 2015 | 1461 | 0.200 |
Why?
|
High-Throughput Screening Assays | 2 | 2023 | 942 | 0.200 |
Why?
|
Weight Loss | 4 | 2018 | 2721 | 0.190 |
Why?
|
Nobel Prize | 1 | 2021 | 46 | 0.190 |
Why?
|
Zebrafish Proteins | 2 | 2019 | 1019 | 0.190 |
Why?
|
Program Development | 1 | 2007 | 1300 | 0.180 |
Why?
|
Fibrinogen | 2 | 2015 | 891 | 0.180 |
Why?
|
Lysophosphatidylcholines | 1 | 2020 | 77 | 0.180 |
Why?
|
Body Temperature | 2 | 2016 | 780 | 0.170 |
Why?
|
Delphi Technique | 1 | 2024 | 891 | 0.170 |
Why?
|
Humans | 54 | 2024 | 768166 | 0.170 |
Why?
|
Protein Kinase C-epsilon | 1 | 2018 | 43 | 0.160 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2019 | 121 | 0.160 |
Why?
|
Alanine Transaminase | 2 | 2016 | 606 | 0.160 |
Why?
|
Gene Expression Regulation | 11 | 2017 | 11928 | 0.160 |
Why?
|
Eating | 2 | 2016 | 1542 | 0.160 |
Why?
|
Glycerides | 1 | 2018 | 67 | 0.160 |
Why?
|
Myostatin | 1 | 2020 | 129 | 0.160 |
Why?
|
Phosphatidylethanolamine Binding Protein | 3 | 2002 | 8 | 0.150 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 135 | 0.150 |
Why?
|
Adiposity | 4 | 2021 | 1895 | 0.150 |
Why?
|
Membrane Fluidity | 1 | 2017 | 67 | 0.150 |
Why?
|
Blood Glucose | 4 | 2017 | 6430 | 0.150 |
Why?
|
Overnutrition | 1 | 2017 | 25 | 0.150 |
Why?
|
Insulin-Secreting Cells | 2 | 2023 | 899 | 0.150 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2018 | 178 | 0.150 |
Why?
|
Bariatric Surgery | 3 | 2016 | 1001 | 0.140 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 7 | 1 | 2016 | 4 | 0.140 |
Why?
|
Animal Feed | 1 | 2017 | 105 | 0.140 |
Why?
|
Glutamine | 2 | 2017 | 577 | 0.140 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 180 | 0.140 |
Why?
|
Pyruvates | 1 | 2016 | 84 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1124 | 0.130 |
Why?
|
Cholesterol, LDL | 3 | 2015 | 2403 | 0.130 |
Why?
|
Atherosclerosis | 3 | 2008 | 3433 | 0.130 |
Why?
|
Lipolysis | 1 | 2017 | 211 | 0.130 |
Why?
|
Recombinant Proteins | 4 | 2020 | 6514 | 0.130 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2018 | 252 | 0.130 |
Why?
|
Animal Experimentation | 1 | 2016 | 46 | 0.130 |
Why?
|
Protein Structure, Tertiary | 4 | 2010 | 3772 | 0.130 |
Why?
|
Hyperammonemia | 1 | 2017 | 80 | 0.130 |
Why?
|
Cold Temperature | 1 | 2020 | 791 | 0.130 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 161 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4249 | 0.130 |
Why?
|
Cholelithiasis | 2 | 2010 | 408 | 0.120 |
Why?
|
Cysteine Endopeptidases | 1 | 2018 | 542 | 0.120 |
Why?
|
Gastrointestinal Contents | 1 | 2015 | 42 | 0.120 |
Why?
|
Trans-Activators | 3 | 2016 | 2857 | 0.120 |
Why?
|
Choline | 1 | 2017 | 522 | 0.120 |
Why?
|
Oxygen Consumption | 2 | 2013 | 1880 | 0.120 |
Why?
|
Protein Binding | 5 | 2018 | 9343 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 845 | 0.120 |
Why?
|
Mice, Transgenic | 6 | 2013 | 9561 | 0.120 |
Why?
|
Methionine | 1 | 2017 | 573 | 0.120 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2014 | 21 | 0.120 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 1 | 2014 | 28 | 0.120 |
Why?
|
Receptors, LDL | 2 | 2015 | 493 | 0.120 |
Why?
|
Substrate Specificity | 2 | 2009 | 1751 | 0.120 |
Why?
|
Hepacivirus | 1 | 2021 | 1344 | 0.110 |
Why?
|
Intestinal Mucosa | 5 | 2015 | 3044 | 0.110 |
Why?
|
Consensus | 1 | 2024 | 3212 | 0.110 |
Why?
|
Panniculitis | 1 | 2014 | 45 | 0.110 |
Why?
|
Liver Diseases | 3 | 2018 | 1305 | 0.110 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2016 | 374 | 0.110 |
Why?
|
Body Composition | 4 | 2017 | 2462 | 0.110 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 2 | 2004 | 64 | 0.110 |
Why?
|
Phosphoproteins | 2 | 2016 | 2451 | 0.110 |
Why?
|
Societies, Medical | 2 | 2015 | 3968 | 0.110 |
Why?
|
Receptors, Thrombin | 1 | 2013 | 130 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 860 | 0.110 |
Why?
|
Coma | 1 | 2017 | 485 | 0.110 |
Why?
|
Transcription Factors | 7 | 2023 | 12168 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2016 | 318 | 0.110 |
Why?
|
Receptors, CXCR3 | 1 | 2014 | 240 | 0.110 |
Why?
|
MicroRNAs | 3 | 2015 | 3803 | 0.110 |
Why?
|
Mucus | 1 | 2015 | 346 | 0.100 |
Why?
|
Cross Reactions | 1 | 2015 | 828 | 0.100 |
Why?
|
Cloning, Molecular | 2 | 2012 | 4168 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 464 | 0.100 |
Why?
|
Kinetics | 3 | 2020 | 6329 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.100 |
Why?
|
Species Specificity | 2 | 2007 | 2415 | 0.100 |
Why?
|
Double-Blind Method | 3 | 2019 | 12465 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2015 | 432 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 12252 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1536 | 0.100 |
Why?
|
Adipocytes | 3 | 2019 | 1197 | 0.100 |
Why?
|
Signal Transduction | 9 | 2020 | 23645 | 0.100 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2019 | 2062 | 0.090 |
Why?
|
Estradiol | 1 | 2019 | 1951 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1206 | 0.090 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2014 | 660 | 0.090 |
Why?
|
Hepatitis C | 1 | 2021 | 1595 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1247 | 0.090 |
Why?
|
Models, Molecular | 3 | 2007 | 5403 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2021 | 3205 | 0.090 |
Why?
|
Malnutrition | 1 | 2017 | 632 | 0.090 |
Why?
|
Fatty Acids, Nonesterified | 2 | 2013 | 394 | 0.090 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2010 | 25 | 0.090 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2253 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2017 | 684 | 0.090 |
Why?
|
Blotting, Western | 2 | 2009 | 5027 | 0.090 |
Why?
|
Crosses, Genetic | 2 | 2009 | 752 | 0.090 |
Why?
|
Adipose Tissue | 4 | 2015 | 3329 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1887 | 0.080 |
Why?
|
Liver Function Tests | 2 | 2014 | 526 | 0.080 |
Why?
|
Gene Targeting | 1 | 2013 | 841 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2010 | 127 | 0.080 |
Why?
|
Fenofibrate | 1 | 2010 | 87 | 0.080 |
Why?
|
Gaucher Disease | 1 | 2010 | 110 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6316 | 0.080 |
Why?
|
Iodide Peroxidase | 1 | 2011 | 295 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2015 | 2486 | 0.080 |
Why?
|
Apoptosis | 1 | 2005 | 9523 | 0.080 |
Why?
|
Membrane Proteins | 4 | 2022 | 7876 | 0.080 |
Why?
|
Cell Membrane | 3 | 2010 | 3655 | 0.080 |
Why?
|
Base Sequence | 2 | 2012 | 12421 | 0.080 |
Why?
|
Osmolar Concentration | 1 | 2009 | 657 | 0.080 |
Why?
|
Protein Folding | 2 | 2009 | 871 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2021 | 18349 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 8054 | 0.070 |
Why?
|
Chylomicrons | 1 | 2007 | 27 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2014 | 19015 | 0.070 |
Why?
|
Biliary Tract | 1 | 2008 | 135 | 0.070 |
Why?
|
Microscopy, Electron | 2 | 2009 | 2560 | 0.070 |
Why?
|
Tissue Distribution | 3 | 2007 | 2300 | 0.070 |
Why?
|
Steroid Hydroxylases | 2 | 2004 | 93 | 0.070 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 263 | 0.070 |
Why?
|
Lipoprotein-X | 1 | 2007 | 5 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2828 | 0.070 |
Why?
|
Phosphorylation | 2 | 2021 | 8317 | 0.070 |
Why?
|
Scavenger Receptors, Class B | 1 | 2007 | 85 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2010 | 1133 | 0.070 |
Why?
|
Fibrosis | 1 | 2014 | 2080 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1110 | 0.070 |
Why?
|
Gallbladder | 2 | 2005 | 308 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3780 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3800 | 0.070 |
Why?
|
Norepinephrine | 1 | 2009 | 898 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2846 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2007 | 463 | 0.070 |
Why?
|
Pulmonary Surfactants | 1 | 2007 | 169 | 0.070 |
Why?
|
Temperature | 2 | 2011 | 2234 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2008 | 859 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1815 | 0.060 |
Why?
|
Cardiovascular Diseases | 4 | 2016 | 15662 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2909 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13290 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3284 | 0.060 |
Why?
|
Lactation | 1 | 2008 | 392 | 0.060 |
Why?
|
Female | 19 | 2020 | 397192 | 0.060 |
Why?
|
Cholesterol, Dietary | 1 | 2005 | 224 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 930 | 0.060 |
Why?
|
Bile Canaliculi | 1 | 2004 | 12 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4580 | 0.060 |
Why?
|
Bezafibrate | 1 | 2004 | 14 | 0.060 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2005 | 84 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3814 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4413 | 0.060 |
Why?
|
CHO Cells | 2 | 2010 | 1379 | 0.060 |
Why?
|
Aspartate Aminotransferases | 1 | 2006 | 414 | 0.060 |
Why?
|
RNA, Messenger | 6 | 2011 | 12800 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2005 | 412 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2013 | 4283 | 0.060 |
Why?
|
Infusions, Parenteral | 1 | 2004 | 396 | 0.060 |
Why?
|
Cell Culture Techniques | 2 | 2009 | 1667 | 0.060 |
Why?
|
Cholestasis | 1 | 2007 | 385 | 0.060 |
Why?
|
Cricetinae | 2 | 2010 | 2423 | 0.050 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2003 | 75 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2010 | 9538 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2810 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2006 | 1989 | 0.050 |
Why?
|
Enzyme Induction | 2 | 2017 | 455 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1730 | 0.050 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2022 | 12 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2479 | 0.050 |
Why?
|
Prognosis | 2 | 2013 | 30010 | 0.050 |
Why?
|
Molecular Structure | 1 | 2007 | 1883 | 0.050 |
Why?
|
Organ Specificity | 1 | 2007 | 1968 | 0.050 |
Why?
|
Cell Line | 3 | 2019 | 15597 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6793 | 0.050 |
Why?
|
Cholesterol, VLDL | 1 | 2002 | 70 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1312 | 0.050 |
Why?
|
Caveolins | 1 | 2002 | 102 | 0.050 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2002 | 262 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1743 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 2003 | 400 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2633 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 2015 | 8128 | 0.050 |
Why?
|
Down-Regulation | 2 | 2008 | 2937 | 0.050 |
Why?
|
Homozygote | 1 | 2006 | 1779 | 0.050 |
Why?
|
Cerebral Ventricles | 1 | 2004 | 550 | 0.050 |
Why?
|
X-Ray Diffraction | 1 | 2002 | 416 | 0.050 |
Why?
|
Cattle | 1 | 2007 | 3819 | 0.050 |
Why?
|
Adrenergic Agonists | 1 | 2021 | 57 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1596 | 0.050 |
Why?
|
Crystallization | 1 | 2002 | 520 | 0.050 |
Why?
|
Organ Size | 2 | 2019 | 2267 | 0.050 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2010 | 1839 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8744 | 0.050 |
Why?
|
Acyltransferases | 1 | 2022 | 306 | 0.040 |
Why?
|
DNA-Binding Proteins | 2 | 2008 | 9615 | 0.040 |
Why?
|
Middle Aged | 7 | 2020 | 223492 | 0.040 |
Why?
|
Isoenzymes | 1 | 2005 | 1688 | 0.040 |
Why?
|
Intracellular Space | 1 | 2021 | 199 | 0.040 |
Why?
|
Lipase | 1 | 2022 | 321 | 0.040 |
Why?
|
Research Design | 1 | 2016 | 6211 | 0.040 |
Why?
|
Consultants | 1 | 2020 | 57 | 0.040 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 58 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 2002 | 1216 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2004 | 2230 | 0.040 |
Why?
|
Growth Differentiation Factors | 1 | 2020 | 99 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5804 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8647 | 0.040 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3706 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13014 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2020 | 426 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 74944 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 65371 | 0.040 |
Why?
|
Liver Transplantation | 2 | 2014 | 2401 | 0.040 |
Why?
|
Drug Resistance | 1 | 2005 | 1599 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24315 | 0.040 |
Why?
|
Protein Transport | 1 | 2004 | 1951 | 0.040 |
Why?
|
Protein Conformation | 1 | 2006 | 3956 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2007 | 1890 | 0.040 |
Why?
|
Cytosol | 1 | 2001 | 887 | 0.040 |
Why?
|
Macrophages | 3 | 2010 | 5799 | 0.040 |
Why?
|
United States | 4 | 2020 | 73039 | 0.040 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 86 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4620 | 0.040 |
Why?
|
Fructokinases | 1 | 2017 | 6 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 125 | 0.040 |
Why?
|
New York | 1 | 2020 | 882 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10873 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2002 | 1951 | 0.040 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2018 | 147 | 0.040 |
Why?
|
tRNA Methyltransferases | 1 | 2017 | 50 | 0.040 |
Why?
|
Sodium Benzoate | 1 | 2017 | 14 | 0.040 |
Why?
|
Ursodeoxycholic Acid | 1 | 2017 | 81 | 0.040 |
Why?
|
Serine | 1 | 2021 | 831 | 0.040 |
Why?
|
Phenylacetates | 1 | 2017 | 112 | 0.040 |
Why?
|
Liver Regeneration | 1 | 2019 | 214 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13671 | 0.030 |
Why?
|
Haplorhini | 1 | 2018 | 523 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2017 | 362 | 0.030 |
Why?
|
Rats | 3 | 2015 | 23760 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 18065 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2018 | 389 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2593 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 3610 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 3035 | 0.030 |
Why?
|
Diethylnitrosamine | 1 | 2015 | 45 | 0.030 |
Why?
|
Aged | 4 | 2020 | 171504 | 0.030 |
Why?
|
Glutamates | 1 | 2017 | 385 | 0.030 |
Why?
|
Deficiency Diseases | 1 | 2016 | 74 | 0.030 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2015 | 58 | 0.030 |
Why?
|
Digestion | 1 | 2015 | 53 | 0.030 |
Why?
|
Weight Gain | 2 | 2019 | 2359 | 0.030 |
Why?
|
Gastrointestinal Hormones | 1 | 2015 | 101 | 0.030 |
Why?
|
Endocrine System | 1 | 2015 | 113 | 0.030 |
Why?
|
Sex Factors | 3 | 2019 | 10632 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 693 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2008 | 393 | 0.030 |
Why?
|
Viscosity | 1 | 2015 | 334 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2015 | 211 | 0.030 |
Why?
|
Embolism, Cholesterol | 1 | 2013 | 32 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2014 | 63 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2014 | 118 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5755 | 0.030 |
Why?
|
Binding Sites | 1 | 2002 | 6020 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2766 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1320 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1906 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2013 | 404 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2013 | 378 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.030 |
Why?
|
Adult | 4 | 2019 | 223646 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2012 | 78 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2019 | 10474 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2014 | 173 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1966 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 1 | 2012 | 229 | 0.020 |
Why?
|
Iceland | 1 | 2011 | 183 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1750 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2016 | 1563 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6340 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10760 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2013 | 769 | 0.020 |
Why?
|
Glucosylceramides | 1 | 2010 | 27 | 0.020 |
Why?
|
Gene Expression | 2 | 2019 | 7598 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8748 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 387 | 0.020 |
Why?
|
Food | 1 | 2015 | 768 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 58 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2003 | 3445 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2011 | 347 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27360 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1151 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2010 | 135 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2018 | 6229 | 0.020 |
Why?
|
Escherichia coli | 1 | 2002 | 4214 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2120 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40218 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13421 | 0.020 |
Why?
|
Intestine, Small | 2 | 2007 | 1217 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2008 | 1793 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 812 | 0.020 |
Why?
|
Steroid 12-alpha-Hydroxylase | 1 | 2008 | 9 | 0.020 |
Why?
|
Cholic Acids | 1 | 2008 | 39 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 824 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2016 | 1862 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1960 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5884 | 0.020 |
Why?
|
Ketones | 1 | 2009 | 183 | 0.020 |
Why?
|
Virus Diseases | 1 | 2014 | 724 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 515 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8890 | 0.020 |
Why?
|
Introns | 1 | 2010 | 966 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2010 | 462 | 0.020 |
Why?
|
Ion Channels | 1 | 2012 | 1043 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 2748 | 0.020 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2007 | 33 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1610 | 0.020 |
Why?
|
Integrases | 1 | 2009 | 520 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2457 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1997 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5349 | 0.020 |
Why?
|
Enterocytes | 1 | 2007 | 220 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 1550 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3603 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7608 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1892 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21538 | 0.010 |
Why?
|
Swine | 1 | 2015 | 5995 | 0.010 |
Why?
|
4-Chloro-7-nitrobenzofurazan | 1 | 2004 | 21 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2538 | 0.010 |
Why?
|
Lysosomes | 1 | 2010 | 938 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2013 | 1388 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2008 | 839 | 0.010 |
Why?
|
Models, Biological | 2 | 2010 | 9495 | 0.010 |
Why?
|
Dietary Carbohydrates | 1 | 2008 | 896 | 0.010 |
Why?
|
Sterols | 1 | 2003 | 64 | 0.010 |
Why?
|
Body Mass Index | 2 | 2011 | 13053 | 0.010 |
Why?
|
Gastrointestinal Transit | 1 | 2003 | 101 | 0.010 |
Why?
|
Detergents | 1 | 2002 | 235 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2629 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2014 | 3073 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2832 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12543 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 514 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5797 | 0.010 |
Why?
|
Caveolin 1 | 1 | 2002 | 255 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20227 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3428 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15948 | 0.010 |
Why?
|
Thrombosis | 1 | 2013 | 2957 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2010 | 2682 | 0.010 |
Why?
|
Phenotype | 2 | 2010 | 16726 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 911 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2002 | 706 | 0.010 |
Why?
|
Capillaries | 1 | 2002 | 755 | 0.010 |
Why?
|
Serum Albumin | 1 | 2002 | 677 | 0.010 |
Why?
|
Capillary Permeability | 1 | 2002 | 772 | 0.010 |
Why?
|
Adenoviridae | 1 | 2002 | 1092 | 0.010 |
Why?
|
Cohort Studies | 2 | 2011 | 41754 | 0.010 |
Why?
|
Integrins | 1 | 2002 | 842 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 30238 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1281 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 36743 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12795 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16045 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 30256 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59629 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2007 | 11095 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 15869 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3728 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 81762 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54926 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4427 | 0.010 |
Why?
|
Genotype | 1 | 2004 | 13045 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 89169 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 17140 | 0.000 |
Why?
|
Lung | 1 | 2002 | 10099 | 0.000 |
Why?
|